Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nitric oxide synthesis is involved in arterial haptoglobin expression after sustained flow changes.

Mirjam B Smeets1, Gerard Pasterkamp, Sai-Kiang Lim

  • 1Experimental Cardiology Laboratory, University Medical Center, Heidelberglaan 100 (room G02.523), 3584 CX Utrecht, The Netherlands.

FEBS Letters
|October 10, 2002
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gene expression profiles of carotid plaques differ between patients with amaurosis fugax and those with cerebral transient ischemic attack or stroke.

Cardiovascular research·2026
Same author

Female-Biased VSMC GRNs Predict MYH9 as Regulator of Fibrous Plaque Phenotype.

Circulation research·2026
Same author

Genetically determined ancestry associates with morphological and molecular carotid plaque features.

Atherosclerosis·2026
Same author

Carotid plaque macrophage burden and inflammatory lipid-associated macrophage markers predict secondary major adverse cardiovascular events after endarterectomy.

European heart journal·2026
Same author

Atherosclerotic Fibrous Plaques in Women Present ECM Remodeling Linked to TGF-β.

Circulation research·2026
Same author

Integrating multi-modal omics to identify therapeutic atherosclerosis pathways for coronary heart disease.

EBioMedicine·2025

Nitric oxide (NO) synthesis regulates arterial haptoglobin expression following flow changes. While NO inhibition decreases haptoglobin and interleukin-6 (IL-6) levels, IL-6 knockout mice show normal arterial haptoglobin, indicating other regulatory factors.

Area of Science:

  • Vascular Biology
  • Biochemistry
  • Immunology

Background:

  • Haptoglobin (Hp) is an acute phase protein highly expressed in arteries, influencing cell migration and arterial remodeling.
  • Interleukin-6 (IL-6) is a primary regulator of hepatic Hp expression, with arterial IL-6 influenced by shear stress and nitric oxide (NO).

Purpose of the Study:

  • To investigate the role of nitric oxide (NO) synthesis in regulating arterial haptoglobin (Hp) expression after sustained changes in blood flow.
  • To explore the relationship between NO, IL-6, and Hp expression in the arterial wall under altered flow conditions.

Main Methods:

  • Utilizing animal models (IL-6 knockout mice) and pharmacological inhibition of NO synthesis.
  • Measuring arterial haptoglobin and IL-6 levels following induced sustained flow changes in arteries.

Related Experiment Videos

Main Results:

  • Nitric oxide (NO) synthesis was found to be involved in the regulation of arterial haptoglobin expression after sustained flow changes.
  • Inhibition of NO synthesis led to decreased arterial haptoglobin expression, which coincided with reduced IL-6 levels.
  • Arterial haptoglobin expression remained normal in IL-6 knockout mice subjected to sustained flow changes, suggesting compensatory mechanisms.

Conclusions:

  • NO synthesis plays a significant role in modulating arterial haptoglobin expression in response to altered blood flow.
  • While IL-6 is a key regulator in the liver, its absence does not prevent normal arterial haptoglobin expression after flow changes, pointing to alternative regulatory pathways.
  • Further research is needed to identify the compensatory mediators involved in arterial haptoglobin regulation when IL-6 is absent.